Shenzhen New Industries Biomedical Engineering (SHE:300832) obtained Class Three medical device registration from China's medical products regulator for its Herpes Simplex Virus Type Two Nucleic Acid detection kit.
The certificate is valid until September 2031, according to a Monday aftermarket filing with the Shenzhen bourse.
The kit is used for in vitro qualitative detection of HSV-2 DNA in male urethral and female cervical swab samples.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments